EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieKlinische Studie (Phase III)Open Access

Diabetes Risk Factors in People With HIV Receiving Pitavastatin Versus Placebo for Cardiovascular Disease Prevention

Kathleen V Fitch, Markella V Zanni iD, Jennifer Manne-Goehler iD, Marissa R Diggs, Arijeet K Gattu, Judith S Currier iD, Gerald S Bloomfield iD, Chiu-Bin Hsiao, Samir K Gupta iD, Judith A Aberg iD, Carlos D Malvestutto iD, Carl J Fichtenbaum iD und 4 weitere

Annals of Internal Medicine · 2024

DOI: 10.7326/annals-24-00944 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Annals of Internal Medicine, 2024. Verfasst von Kathleen V Fitch und 15 weiteren Autor:innen. Beteiligte Einrichtung: Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (K.V.F., M.V.Z., M.R.D., A.K.G., S.K.Gupta). Hauptthemen laut MEDLINE: Quinolines, HIV Infections, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cardiovascular Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuinolinesHIV InfectionsHydroxymethylglutaryl-CoA Reductase InhibitorsCardiovascular DiseasesHumansMiddle AgedMaleFemaleAdultAgedRisk FactorsDiabetes Mellitus

Substanzen

pitavastatinQuinolinesHydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (K.V.F., M.V.Z., M.R.D., A.K.G., S.K.Gupta).
  • Division of Infectious Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (J.M.-G.).
  • Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California (J.S.C.).
  • Department of Medicine, Duke Global Health Institute and Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina (G.S.B.).
  • Division of Infectious Diseases, Drexel University College of Medicine, Philadelphia, Pennsylvania (C.-B.H.).
  • Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, New York (J.A.A.).

ORCID-Profile: Markella V Zanni, Jennifer Manne-Goehler, Judith S Currier, Gerald S Bloomfield, Samir K Gupta, Judith A Aberg, Carlos D Malvestutto, Carl J Fichtenbaum, Michael T Lu, Pamela S Douglas, Heather J Ribaudo

Förderung

  • NIAID NIH HHS
  • NHLBI NIH HHS
  • NCATS NIH HHS
  • NIDDK NIH HHS

Zitieren

APA

Fitch, K. V., Zanni, M. V., Manne-Goehler, J., Diggs, M. R., Gattu, A. K., Currier, J. S., Bloomfield, G. S., Hsiao, C. B., Gupta, S. K., Aberg, J. A., Malvestutto, C. D., Fichtenbaum, C. J., Lu, M. T., Douglas, P. S., Ribaudo, H. J., & Grinspoon, S. K. (2024). Diabetes Risk Factors in People With HIV Receiving Pitavastatin Versus Placebo for Cardiovascular Disease Prevention. Annals of Internal Medicine. https://doi.org/10.7326/annals-24-00944

Vancouver

Fitch KV, Zanni MV, Manne-Goehler J, Diggs MR, Gattu AK, Currier JS, et al. Diabetes Risk Factors in People With HIV Receiving Pitavastatin Versus Placebo for Cardiovascular Disease Prevention. Annals of Internal Medicine. 2024. doi:10.7326/annals-24-00944

BibTeX
@article{Fitch2024,
  author = {Fitch, Kathleen V and Zanni, Markella V and Manne-Goehler, Jennifer and Diggs, Marissa R and Gattu, Arijeet K and Currier, Judith S and Bloomfield, Gerald S and Hsiao, Chiu-Bin and Gupta, Samir K and Aberg, Judith A and Malvestutto, Carlos D and Fichtenbaum, Carl J and Lu, Michael T and Douglas, Pamela S and Ribaudo, Heather J and Grinspoon, Steven K},
  title = {Diabetes Risk Factors in People With HIV Receiving Pitavastatin Versus Placebo for Cardiovascular Disease Prevention},
  journal = {Annals of Internal Medicine},
  year = {2024},
  doi = {10.7326/annals-24-00944}
}
Kostenlos starten →